Drug Search Results
More Filters [+]

Valnoctamide

Alternative Names: valnoctamide
Latest Update: 2022-04-23
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Italy

Approved Indications: None

Known Adverse Events: None

Company: Beersheva Mental Health Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Valnoctamide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Psychotic Disorders|Schizophrenia|Affective Disorders, Psychotic|Bipolar Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

BMHC-3658

P3

Completed

Psychotic Disorders|Schizophrenia|Affective Disorders, Psychotic|Bipolar Disorder

None

Recent News Events